Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,012 | 57,475 | 72,287 | 22,597 | 34,849 |
| TOTAL | $105,530 | $59,737 | $72,925 | $23,360 | $35,209 |
| Non-Current Assets | |||||
| PPE Net | 2,978 | 2,926 | 2,882 | 2,857 | 2,733 |
| Other Non-Current Assets | 130 | 130 | 130 | 153 | 148 |
| TOTAL | $3,108 | $3,056 | $3,012 | $3,010 | $2,881 |
| Total Assets | $108,638 | $62,793 | $75,937 | $26,370 | $38,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,769 | 3,603 | 1,264 | 2,250 | 5,350 |
| Accrued Expenses | 5,540 | 2,617 | 4,339 | 2,360 | 3,488 |
| TOTAL | $10,792 | $7,384 | $6,992 | $5,498 | $9,592 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $10,792 | $7,384 | $6,992 | $5,498 | $9,592 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,911 | 23,902 | 23,724 | 15,681 | 15,348 |
| Common Shares | 289 | 239 | 237 | 3,110 | 3,060 |
| Retained earnings | -275,419 | -256,408 | -238,870 | -224,827 | -211,954 |
| TOTAL | $97,846 | $55,409 | $68,945 | $20,872 | $28,498 |
| Total Liabilities And Equity | $108,638 | $62,793 | $75,937 | $26,370 | $38,090 |